Found: 12
Select item for more details and to access through your institution.
Bacterial stroke-associated pneumonia: microbiological analysis and mortality outcome.
- Published in:
- BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03755-4
- By:
- Publication type:
- Article
The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 12, p. 1666, doi. 10.3390/antibiotics12121666
- By:
- Publication type:
- Article
Evaluating physicians' awareness and prescribing trends regarding proton pump inhibitors: a cross-sectional study.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1241766
- By:
- Publication type:
- Article
Galangal–Cinnamon Spice Mixture Blocks the Coronavirus Infection Pathway through Inhibition of SARS-CoV-2 M Pro , Three HCoV-229E Targets; Quantum-Chemical Calculations Support In Vitro Evaluation.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 10, p. 1378, doi. 10.3390/ph16101378
- By:
- Publication type:
- Article
Clinical Care Team's Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 9, p. 1645, doi. 10.3390/medicina59091645
- By:
- Publication type:
- Article
Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1215, doi. 10.3390/ph16091215
- By:
- Publication type:
- Article
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 868, doi. 10.3390/ph16060868
- By:
- Publication type:
- Article
Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein—In Silico and In Vitro Evidence.
- Published in:
- Molecules, 2022, v. 27, n. 21, p. 7383, doi. 10.3390/molecules27217383
- By:
- Publication type:
- Article
Anti-cancer Effect of Hyoscyamus muticus Extract via Its Activation of Fas/FasL-ASK1-p38 Pathway.
- Published in:
- Biotechnology & Bioprocess Engineering, 2022, v. 27, n. 5, p. 807, doi. 10.1007/s12257-022-0085-x
- By:
- Publication type:
- Article
Effect of Celecoxib and Infliximab against Multiple Organ Damage Induced by Sepsis in Rats: A Comparative Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071613
- By:
- Publication type:
- Article
Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNAdependent RNA polymerase.
- Published in:
- Pharmacia (0428-0296), 2022, v. 69, n. 1, p. 211, doi. 10.3897/pharmacia.69.e77021
- By:
- Publication type:
- Article
In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.9163
- By:
- Publication type:
- Article